Orbicular Pharmaceutical Technologies Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
- Paid Up Capital ₹ 11.18 Cr
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 193.02 Cr
- Satisfied Charges ₹ 14.70 Cr
- Revenue Growth -24.27%
- Profit Growth -42.36%
- Ebitda 10.81%
- Net Worth 20.30%
- Total Assets 17.42%
About Orbicular Pharmaceutical Technologies
Orbicular Pharmaceutical Technologies Private Limited (OPTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 August 2008 and has a history of 16 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.18 Cr.
The company currently has active open charges totaling ₹193.02 Cr. The company has closed loans amounting to ₹14.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Meena Mohan, Mohan Mailtur, Hiren Patel, and Three other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233TG2008PTC060606
- Company No.
060606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
What products or services does Orbicular Pharmaceutical Technologies Private Limited offer?
Orbicular Pharmaceutical Technologies Private Limited offers a wide range of products and services, including Corporate and Soft Skills Training, Corporate Training, Company Law & Labour Law Consultants, Statutory Compliance Services, Software Development & IT Consultant, Software Consulting Service, Urological & Obstetrics Instruments, Gynaecological Equipment.
Orbicular Pharmaceutical Technologies Private Limited
Explore comprehensive data for Orbicular Pharmaceutical Technologies Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Orbicular Pharmaceutical Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Mailtur  | Managing Director | 06-Aug-2010 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Mohan | Director | 13-Aug-2008 | Current |
| Bhavesh Patel | Director | 01-Apr-2022 | Current |
| Hiren Patel | Director | 24-Aug-2012 | Current |
| Visalakshi Chandramouli | Nominee Director | 06-Jun-2024 | Current |
| Rahul Sudhakar | Director | 01-Jul-2019 | Current |
Financial Performance of Orbicular Pharmaceutical Technologies.
Orbicular Pharmaceutical Technologies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.27% decrease. The company also saw a substantial fall in profitability, with a 42.36% decrease in profit. The company's net worth Soared by an impressive increase of 20.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orbicular Pharmaceutical Technologies?
In 2023, Orbicular Pharmaceutical Technologies had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Revitos Specialities Private LimitedMeena Mohan and Rahul Sudhakar are mutual person
Invitron Advanced Analytics Private LimitedMeena Mohan, Mohan Mailtur and 3 more are mutual person
Sakar Healthcare LimitedVisalakshi Chandramouli is a mutual person
Linux Laboratories Private LimitedVisalakshi Chandramouli is a mutual person
Anderson Diagnostic Services Private LimitedVisalakshi Chandramouli is a mutual person
Deeptek Medical Services Private LimitedVisalakshi Chandramouli is a mutual person
Charges (Loans)
Open Charges
₹193.02 Cr
Satisfied Charges
₹14.70 Cr
Charges Breakdown by Lending Institutions
- Others : 193.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2024 | Others | ₹14.00 Cr | Open |
| 20 Apr 2023 | Others | ₹11.80 Cr | Open |
| 24 Nov 2022 | Others | ₹5.50 Cr | Open |
| 24 Nov 2022 | Others | ₹5.00 Cr | Open |
| 26 Aug 2022 | Others | ₹40.01 Cr | Open |
How Many Employees Work at Orbicular Pharmaceutical Technologies?
Orbicular Pharmaceutical Technologies has a workforce of 218 employees as of Oct 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orbicular Pharmaceutical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbicular Pharmaceutical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Orbicular Pharmaceutical Technologies
Recent activity within the organization
- Director Appointment
Visalakshi Chandramouli was appointed as a Nominee Director was appointed as a Nominee Director on 06 Jun 2024 & has been associated with this company since 9 months 6 days .
- Charges
A charge with Others amounted to Rs. 14.00 Cr with Charge ID 100939862 was registered on 24 May 2024.
- Charges
A charge with Others of Rs. 11.80 Cr registered on 20 Apr 2023 with Charge ID 100725078 was modified on 30 Apr 2024.
- Charges
A charge with Others of Rs. 78.52 Cr registered on 14 Feb 2017 with Charge ID 100084285 was modified on 22 Jan 2024.
- Annual General Meeting
Orbicular Pharmaceutical Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with Others of Rs. 27.50 Cr registered on 23 Aug 2021 with Charge ID 100499062 was modified on 30 Aug 2023.
Recent News, Updates & Announcement
- "Alembic and Orbicular Form Aleor Dermaceuticals to Meet Global Demand for Dermatology Products".
Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies have joined forces to create Aleor Dermaceuticals, with Alembic holding 60% and Orbicular holding the rest. They will manufacture and sell dermatology products globally and have set up a manufacturing facility for this purpose. The details of the venture and investments were not disclosed. Orbicular has expertise in developing dermatology products and has a research lab in Hyderabad. This move is in line with the growing demand for dermatology products due to lifestyle and environmental changes..
Frequently asked questions
What is the Incorporation or founding date of Orbicular Pharmaceutical Technologies Private Limited?
Orbicular Pharmaceutical Technologies Private Limited was incorporated on 13 Aug 2008.
What is authorized share capital and paid-up capital of Orbicular Pharmaceutical Technologies Private Limited?
The authorized share capital of Orbicular Pharmaceutical Technologies Private Limited is ₹ 12.00 Cr and paid-up capital is ₹ 11.18 Cr.
Who are the current board members & directors of Orbicular Pharmaceutical Technologies Private Limited?
Currently 6 directors are associated with Orbicular Pharmaceutical Technologies Private Limited.
- Meena Mohan
- Mohan Sivaraman Mailtur
- Hiren Dasharathbhai Patel
- Visalakshi Chandramouli
- Rahul Gawande Sudhakar
- Bhavesh Vallabhbhai Patel
What is the registered address of Orbicular Pharmaceutical Technologies Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Orbicular Pharmaceutical Technologies Private Limited is P.No 53 Aleap Industrial Estate Gajularamaram Behind Pragathi Nagar, Kukatpally India, Hyderabad, Telangana, 500090.
What is the corporate identification number (CIN) and company number of Orbicular Pharmaceutical Technologies Private Limited?
The corporate identification number (CIN) of Orbicular Pharmaceutical Technologies Private Limited is U24233TG2008PTC060606 and the company number is 060606 as per Ministry of Corporate Affairs (MCA).
What is the official website of Orbicular Pharmaceutical Technologies Private Limited?
The Official website of Orbicular Pharmaceutical Technologies Private Limited is https://www.orbicular.co.in
What has been the recent revenue trend for Orbicular Pharmaceutical Technologies Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Orbicular Pharmaceutical Technologies Private Limited has fallen by -24.27%.
How many employees does Orbicular Pharmaceutical Technologies Private Limited currently have?
As Per 2023 financial reports, 218 employees are currently employed by Orbicular Pharmaceutical Technologies Private Limited.
What change has been observed in the net worth of Orbicular Pharmaceutical Technologies Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Orbicular Pharmaceutical Technologies Private Limited has experienced an upsurge of 20.30%.
What are the total open charges for Orbicular Pharmaceutical Technologies Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Orbicular Pharmaceutical Technologies Private Limited amount to ₹ 193.02 Cr.
When was the last Balance Sheet of Orbicular Pharmaceutical Technologies Private Limited filed with the ROC?
The most recent Balance Sheet for Orbicular Pharmaceutical Technologies Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
HS
Himanshu ShahAdditional DirectorMS
Melarkode SivaramanDirector